Gene Query: CEP44

Dataset Description Geneva Score
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 57.21
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 43.59
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 19.76
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 17.65
Targeting EZH2 in MYCN-amplified Neuroblastoma 17.65
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 13.87
Tracking distinct RNA populations using efficient and reversible covalent chemistry 13.23
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 13.05
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 12.62
RNA sequencing of matched nephrectomy samples [RNA-seq] 12.62
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 12.4
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 12.32
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 11.79
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 10.62
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 10.3
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 10.3
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 10.3
Recovery and analysis of nascent RNA 10.3
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 9.61
U2AF1 mutations alter splice site recognition in hematological malignancies 9.13
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 9.1
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 8.95
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 8.87
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 8.12
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 8.03
Oncogenic MYC induces a dependency on the spliceosome in human cancer 7.54
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 7.31
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 7.21
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 6.61
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 6.6
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 6.52
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 6.52
Gene expression profile of human iPSC-derived nephron progenitor cells 6.41
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 6.33
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 6.31
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 6.31
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 6.28
FOXP2's impact on the primate transcriptome 6.22
O-glcnAc reprograms cellular energetics 6.15
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 6.14
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 5.84
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 5.6
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 5.52
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 5.46
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 5.42
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 5.42
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 5.32
The pause-initiation limit restricts transcription activation in human cells 5.28
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 5.22
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 5.16
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 5.07
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 5.06
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 4.95
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 4.9
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 4.9
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 4.88
The regulartory role of ZCCHC24 in splicing machinery 4.87
MYCL and EP400 are required for Max and MCPyV mediated gene activation 4.83
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 4.8
Gene expression changes after LOC550643 silencing 4.68
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 4.68
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.61
RNA-seq of YB5 cells treated with Proscillaridin A 4.56
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 4.47
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 4.29
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 4.25
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 4.24
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 4.24
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 4.22
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 4.18
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 4.18
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 4.13
Impact of dieldrin on transcription in Jurkat T cells 4.09
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 4.06
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 3.96
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 3.95
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 3.89
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 3.89
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 3.88
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 3.87
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 3.84
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 3.79
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 3.77
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 3.72
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 3.72
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 3.72
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 3.72
Ribosomal footprinting of MDA-Parental and MDA-LM2 3.69
Human cell line and subcutaneous tumor 3.67
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 3.64
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 3.64
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 3.62
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 3.6
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 3.6
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 3.59
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 3.58
Rorc disruption in human FG pancreatic cancer cells 3.48
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 3.39
Primate-specific gene TMEM14B promotes cortical expansion and folding 3.36
SETBP1-WT and SETBP1-G870S epigenetic landscapes 3.34
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 3.34
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 3.34
AUF-1 affected genes in human skin cells 3.3
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 3.27
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 3.27
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 3.25
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 3.25
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 3.22
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 3.22
Ribosomal footprinting of CN34-Parental and CN34-LM1a 3.21
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 3.2
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 3.16
Global transcriptome analysis of HAP1 cells 3.12
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 3.11
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 3.09
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 3.08
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 3.07
SRSF2 mutations impair hematopoiesis and alter exon recognition 3.04
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 3.0
Changes in human endometrial gland transcriptome over the window of implantation 2.98
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 2.97
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 2.94
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 2.94
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 2.93
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 2.92
Mutational landscape of splicing genes and functional consequences across 33 cancer types 2.91
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 2.86
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 2.86
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 2.86
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 2.85
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 2.81
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 2.8
The cohesin release factor WAPL restricts chromatin loop extension. 2.8
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 2.78
Gene expression in PANC1 cells treated with Rakicidin 2.75
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 2.75
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 2.74
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 2.73
Transciptomic profiling of human fetal lung samples 2.73
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 2.73
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 2.71
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 2.7
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 2.62
RNAseq analysis of ESRP regulated splicing events in prostate cancer 2.61
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 2.6
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 2.57
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 2.57
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 2.57
Single-cell analysis of human kidney organoids 2.56
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 2.55
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 2.54
Zika infected neural stem cells 2.49
Transcriptome analysis of Zika infected neural stem cells 2.49
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 2.49
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 2.48
ChIP-seq and RNA-seq from human lymphoma cell lines 2.47
RNA-seq data from human lymphoma cell lines 2.47
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 2.47
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 2.46
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 2.45
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 2.44
Effect of PRDM11 depletion in U2932 cells 2.44
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 2.44
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 2.42
TOP2B disturbed the quality of human oocytes with advanced maternal age 2.41
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 2.41
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 2.4
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 2.39
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 2.39
HEK293 TFAM Knockout Expression Study 2.37
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 2.37
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 2.37
CROP-Seq in Primary Human T Cells 2.35
Cerebellar differentiation in Ataxia-Telangiectasia 2.34
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 2.32
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 2.31
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 2.31
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 2.31
HNRNPM-regulated splicing dependencies in prostate cancer 2.3
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 2.3
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 2.29
Identification of global regulators of T-helper cell lineage specification 2.29
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 2.29
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 2.29
Hypoxic transcriptome of SQ20B human head and neck cancer cells 2.28
A Unique Epigenomic Landscape Defines Human Erythropoiesis 2.28
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 2.28
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 2.26
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 2.25
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 2.25
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 2.24
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 2.24
RNA sequencing of primary human platelets and in vitro cell lines 2.23
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 2.22
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 2.22
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 2.21
RNA-seq analyisis of PUM2 knockout cells 2.21
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 2.21
Determination of tRNA aminoacylation levels by high throughput sequencing 2.2
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 2.2
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 2.19
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 2.18
WRN knockout effects upon gene expression in SW48 and OVK18 2.17
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 2.15
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 2.12
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 2.12
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 2.12
Polarized B -cell functions 2.11
Targeting MTHFD2 in Acute Myeloid Leukemia 2.11
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 2.11
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 2.11
NHLRC1 re-expression in cancer cells 2.1
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 2.1
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 2.09
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 2.06
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 2.04
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 2.04
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 2.02
Analysis of transcriptional regulation by Myt1 and Myt1l 1.99
Comprehensive comparative analysis of 5’ end RNA sequencing methods 1.99
Gene expression profiling of leukemia cells following asparagine depletion 1.97
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.96
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 1.96
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 1.96
Genome wide miR-191 target profile determined by RIP and gene expression profiling 1.95
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 1.95
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 1.94
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 1.89
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 1.87
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 1.87
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 1.87
MicroRNA-125a-5p overexpression in human macrophages 1.85
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 1.85
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 1.85
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 1.83
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 1.8
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 1.79
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 1.79
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 1.76
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 1.75
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 1.75
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 1.73
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 1.73
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 1.73
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 1.72
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 1.7
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.7
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 1.68
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 1.68
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.68
Single-Cell Genotyping of Transcriptomes 1.68
hnRNP C is a key regulator of protein synthesis in mitosis 1.68
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 1.65
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 1.64
JunB control of keratinocyte-mediated inflammation [RNA-seq] 1.64
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 1.64
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 1.64
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 1.64
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 1.64
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 1.63
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 1.61
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 1.6
RNA-seq of tumor cells following angiopellosis extravasation 1.6
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 1.6
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 1.58
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 1.58
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 1.58
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 1.57
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 1.57
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 1.57
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 1.57
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 1.55
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 1.53
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 1.53
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 1.53
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 1.52
Global Mapping of Human RNA-RNA Interactions 1.51
Controlling for gene expression changes in transcription factor protein networks. 1.51
Global transcriptome analysis of WT versus HEB-/- hESCs 1.49
Profiling of escape kinetics of viruses subjected to RNAi 1.49
Gene expression profile in breast cancer cells 1.44
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.44
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 1.42
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 1.42
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 1.41
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 1.41
Gene expression in GBM with Cav3.2 inhibition 1.41
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 1.4
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 1.4
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 1.39
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 1.39
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 1.38
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 1.38
Transcription control by the ENL YEATS domain in acute leukemia 1.38
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 1.38
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 1.37
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 1.37
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 1.37
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 1.36
ARID1A and ARID1B loss in HCT116 and TOV21G cells 1.35
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 1.34
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 1.31
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 1.31
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 1.3
Regulation of poly(A) tail and translation during the somatic cell cycle 1.29
Bone marrow derived human B cells [normal proB] 1.28
LIN28A Over-expression RNAseq 1.28
Lysine benzoylation is a novel histone mark 1.28
Lysine benzoylation is a novel histone mark [RNA-seq] 1.28
Generation of KRAS signatures using immortalized isogenic lung cells. 1.27
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 1.27
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 1.27
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.26
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 1.25
Oncogenic roles of ARID5B in T-ALL 1.25
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 1.24
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 1.23
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 1.21
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 1.21
Regulation of protein translation during mitosis 1.21
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 1.2
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 1.19
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 1.19
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 1.18
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 1.14
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 1.13
Cajal bodies are linked to genome conformation [RNA-Seq] 1.13
Cajal bodies are linked to genome conformation 1.13
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 1.13
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 1.13
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 1.11
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 1.11
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 1.1
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 1.09
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 1.07
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 1.06
Gene expression signatures of innate lymphoid cells from human blood 1.06
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.05
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.05
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 1.05
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 1.04
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 1.03
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 1.03
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 0.99
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 0.99
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.99
The effect of insulin on mRNA transcription of human pluripotent stem cells 0.98
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.96
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.96
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 0.96
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 0.96
Human Treg NaCl stimulation 0.95
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 0.95
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 0.95
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 0.95
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 0.94
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 0.93
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.93
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.93
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 0.89
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 0.88
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.86
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 0.85
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 0.85
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.85
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.84
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.84
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.82
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.81
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.81
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.81
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.81
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 0.8
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 0.8
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.8
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 0.79
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.79
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 0.77
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.77
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 0.76
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 0.76
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 0.76
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 0.75
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 0.75
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 0.75
Gene expression changes due to PARP knockdown in human cells 0.74
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 0.72
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.72
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 0.72
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 0.72
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.72
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.71
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.68
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.68
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.66
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 0.65
KSDM1b Role in Ewing Sarcoma 0.65
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.63
ML29755 RNA-seq data 0.61
EWSR1 influences alternative splicing through direct and indirect mechanisms 0.59
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.58
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.58
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 0.56
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.56
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 0.56
Transcriptome-wide modulation of splicing by the exon junction complex 0.56
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 0.55
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.54
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.53
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.5
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.5
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.49
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 0.48
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.48
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.47
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.47
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.46
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.46
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.45
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.45
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 0.45
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.45
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.45
Functional significance of the HIV-1 Tat signature amino acid residues 0.44
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.44
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.43
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 0.42
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.42
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.41
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.41
6mer seed toxicity in tumour suppressive microRNAs 0.41
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.4
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.4
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 0.39
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 0.37
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 0.36
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.36
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.36
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 0.35
Differentiation enhances Zika virus infection in neuronal brain cells 0.34
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 0.34
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 0.34
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.31
Genome-wide analysis of the Integrator complex (HTS) 0.31
Genome-wide analysis of the Integrator complex 0.31
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.3
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.3
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.3
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 0.29
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 0.29
Persistence of stem cell metabolism in cancers as a failure of differentiation 0.28
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.28
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.27
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 0.26
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 0.25
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.24
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 0.22
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.22
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.21
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 0.21
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.21
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 0.21
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.2
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.2
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 0.2
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.2
Gene expression analysis in response to hypoxic pathway inhibition 0.2
Role of FGFR1 in neuronal devlopment 0.19
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.18
RNA-Seq of the corpus callosum from 12 individuals 0.18
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.17
Impact on erythroid progenitor type on erythroid differntiation 0.14
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.14
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 0.13
Gene expression analysis upon mtDNA depletion 0.13
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.13
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.13
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.13
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.13
Modulation of nonsense-mediated decay by rapamycin 0.11
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.09
Transcriptional landscape changes during human embryonic stem cell derivation 0.09
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  0.08
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.08
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 0.07
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.07
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.06
Epigenomic conservation of transposable element silencing [RNA-seq] 0.04
Epigenomic conservation of transposable element silencing 0.04
RNA seq analysis of human Fetal and adult derived Enterospheres 0.03
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.02
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.02
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.01
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.01
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 0.01
Preclinical model of obesity and ER-positive breast cancer 0.01
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01
Identification of a LIF-responsive replication-competent human β cell 0.01
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.0
Total RNA-seq in ALL-SIL upon TLX1 knockdown 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation